NEW YORK, May 17 /PRNewswire-Asia/ -- Tiens Biotech Group (USA), Inc. (the
"Company" or "Tiens", NYSE AMEX: TBV), http://www.tiens-bio.com , today
announced financial results for the first quarter ended March 31, 2010.

Revenue for the first quarter of 2010 was $11.4 million, compared to $18.2
million for the first quarter of 2009.

Net income for the first quarter of 2010 was $3.6 million, or $0.05 per
share, compared to $9.0 million, or $0.12 per share for 2009.

Revenue in China increased to $6.8 million for the first quarter of 2010,
compared to $2.7 million for the same period in 2009. The Company's 2010 first
quarter sales in China was, however, comparable to the 2009 average quarterly
sales in China of $6.8 million. Management believes that Tianshi Engineering's
announced plans to increase prices of its products during the third quarter of
2008 prompted customers to stock up on certain products in late 2008, thereby
decreasing customer demand in the first quarter of 2009. Revenue in '/>"/>

(Date:7/29/2015)... -- According to a new market research report, ... (2015-2020), , published by Mordor Intelligence, the Global market is ... of 2020, with North America being ... the global market size. The Global market for Stem Cells ... the period of (2015-2020). (Logo: http://photos.prnewswire.com/prnh/20150428/740799) , ...

(Date:7/29/2015)... -- Indivior PLC (LON: INDV) today announced that the New ... and received Priority Review by the U.S. Food and ... This naloxone nasal spray comes as a pre-filled device ... the nasal mucosa. 1 The device has been ... better equipped to help an opioid overdose victim. ...

... (Ferrari), is considered one of the most serious ... beetle are difficult to combat; most of the insect,s ... and contact difficult. Female beetles bore holes into developing ... and create ,galleries, where they remain and deposit their ...